NPTX2 and early-onset autosomal dominant Alzheimer disease: Our findings support the hypothesis that NPAS-4 and NPTX-2 are involved in the pathophysiological process of Alzheimer’s disease and may serve as potential biomarkers for early diagnosis and monitoring of disease progression.